An eye toward the clinic, Israel’s Compugen works to transform itself admin June 8, 2017 Blog Read more: https://www.bioworld.com/report/BWT053017Compugen.pdf You Might Also Like U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery April 26, 2018 VBL posts additional data from phase 2 thyroid cancer trial February 23, 2017 MeMed Wins $9.2M DTRA Contract for PoC IVD to Reduce Antibiotic Misuse April 19, 2017
U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery April 26, 2018
